Sci­ence-whiz twins backed by a16z bring Func­tion On­col­o­gy out of stealth

While the drug in­dus­try has de­vel­oped dozens of drugs tar­get­ing spe­cif­ic pro­teins or genes in­volved in can­cer, a new San Diego start­up hopes to su­per­charge the im­pact of those tar­get­ed ther­a­pies with a new ap­proach to match­ing drugs to in­di­vid­ual pa­tient’s tu­mors.

Run by twin broth­ers who have been to­geth­er through child­hood, aca­d­e­mics and in­dus­try, Func­tion On­col­o­gy came out of stealth on Wednes­day, about a year and a half af­ter rais­ing a $28 mil­lion Se­ries A round co-led by a16z and Sec­tion 32.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER